Press Releases
Filters
July 3, 2024
Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business Divestiture
July 2, 2024
U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation
June 26, 2024
Viatris Statement Regarding European Commission’s Approval for Proposed Divestiture of its Over-the-Counter Business to Cooper Consumer Health
June 4, 2024
Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
June 3, 2024
Viatris Statement on the Close of the Active Pharmaceutical Ingredients Business Divestiture
May 21, 2024
Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale
Displaying 1 - 10 of 108